|1.||Sharif, Najam A: 2 articles (08/2010 - 02/2007)|
|2.||Kelly, Curtis R: 1 article (02/2007)|
|3.||McLaughlin, Marsha A: 1 article (02/2007)|
|1.||Ocular Hypertension (Glaucoma, Suspect)
08/01/2010 - "As a result of further structure-activity investigations, AL-34662, a selective 5HT(2) agonist (relative to other 5HT receptor types and sub-types) with high affinity, potency and efficacy at 5HT(2A), 5HT(2B) and 5HT(2C) receptors was discovered that efficaciously lowered IOP in the monkey model of ocular hypertension (33 +/- 3 % reduction out to 6 hrs post with a 300 microg topical ocular dose). "
|1.||trichostatin A (A 300)